Seeking Alpha

BioMarin Pharmaceutical (BMRN): Q4 EPS of -$0.23 misses by $0.13. Revenue of $107.9M (+6.1% Y/Y)...

BioMarin Pharmaceutical (BMRN): Q4 EPS of -$0.23 misses by $0.13. Revenue of $107.9M (+6.1% Y/Y) misses by $8M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|